Radioiodine treatment after surgery for differentiated thyroid cancer: a reasonable option

@article{Clerc2017RadioiodineTA,
  title={Radioiodine treatment after surgery for differentiated thyroid cancer: a reasonable option},
  author={J{\^e}rome Clerc and Frederik Anton Verburg and Anca M. Avram and Luca Giovanella and Elif Hindi{\'e} and David Ta{\"i}eb},
  journal={European Journal of Nuclear Medicine and Molecular Imaging},
  year={2017},
  volume={44},
  pages={918-925}
}
Until recently, the usual treatment for differentiated thyroid cancers (DTC)with a size >1.0 cm undisputedly consisted of total or near-total thyroidectomy followed by radioiodine administration. Observational data support lower recurrence rates after radioiodine treatment (RAI) following surgery [1–3]. In recent years, and especially so since the publication of the 2015 American Thyroid Association (ATA) differentiated thyroid cancer guidelines (DTC) [4], the systematic use of RAI has declined… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-7 OF 7 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 51 REFERENCES

: the american thyroid association guidelines task force on thyroid nodules and differentiated

FA Verburg, U Mader, C Reiners, H Hanscheid
  • thyroid cancer
  • 2016

How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2016
VIEW 1 EXCERPT

Current controversies in the initial post-surgical radioactive iodine therapy for thyroid cancer: a narrative review

R Blumhardt, EA Wolin, PhillipsWT
  • Endocr Relat Cancer
  • 2014
VIEW 1 EXCERPT